Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan 31;91(4):e01979-16.
doi: 10.1128/JVI.01979-16. Print 2017 Feb 15.

Thymidine Kinase-Negative Herpes Simplex Virus 1 Can Efficiently Establish Persistent Infection in Neural Tissues of Nude Mice

Affiliations

Thymidine Kinase-Negative Herpes Simplex Virus 1 Can Efficiently Establish Persistent Infection in Neural Tissues of Nude Mice

Chih-Yu Huang et al. J Virol. .

Abstract

Herpes simplex virus 1 (HSV-1) establishes latency in neural tissues of immunocompetent mice but persists in both peripheral and neural tissues of lymphocyte-deficient mice. Thymidine kinase (TK) is believed to be essential for HSV-1 to persist in neural tissues of immunocompromised mice, because infectious virus of a mutant with defects in both TK and UL24 is detected only in peripheral tissues, but not in neural tissues, of severe combined immunodeficiency mice (T. Valyi-Nagy, R. M. Gesser, B. Raengsakulrach, S. L. Deshmane, B. P. Randazzo, A. J. Dillner, and N. W. Fraser, Virology 199:484-490, 1994, https://doi.org/10.1006/viro.1994.1150). Here we find infiltration of CD4 and CD8 T cells in peripheral and neural tissues of mice infected with a TK-negative mutant. We therefore investigated the significance of viral TK and host T cells for HSV-1 to persist in neural tissues using three genetically engineered mutants with defects in only TK or in both TK and UL24 and two strains of nude mice. Surprisingly, all three mutants establish persistent infection in up to 100% of brain stems and 93% of trigeminal ganglia of adult nude mice at 28 days postinfection, as measured by the recovery of infectious virus. Thus, in mouse neural tissues, host T cells block persistent HSV-1 infection, and viral TK is dispensable for the virus to establish persistent infection. Furthermore, we found 30- to 200-fold more virus in neural tissues than in the eye and detected glycoprotein C, a true late viral antigen, in brainstem neurons of nude mice persistently infected with the TK-negative mutant, suggesting that adult mouse neurons can support the replication of TK-negative HSV-1.

Importance: Acyclovir is used to treat herpes simplex virus 1 (HSV-1)-infected immunocompromised patients, but treatment is hindered by the emergence of drug-resistant viruses, mostly those with mutations in viral thymidine kinase (TK), which activates acyclovir. TK mutants are detected in brains of immunocompromised patients with persistent infection. However, answers to the questions as to whether TK-negative (TK-) HSV-1 can establish persistent infection in brains of immunocompromised hosts and whether neurons in vivo are permissive for TK- HSV-1 remain elusive. Using three genetically engineered HSV-1 TK- mutants and two strains of nude mice deficient in T cells, we found that all three HSV-1 TK- mutants can efficiently establish persistent infection in the brain stem and trigeminal ganglion and detected glycoprotein C, a true late viral antigen, in brainstem neurons. Our study provides evidence that TK- HSV-1 can persist in neural tissues and replicate in brain neurons of immunocompromised hosts.

Keywords: herpes simplex virus 1; mice; neural tissues; persistent infection; thymidine kinase.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Acute replication of HSV-1 in ICR mice. Viral titers in the eyes (A), trigeminal ganglia (B and D), and brain stems (C and E) of ICR wild-type (WT) and nude mice infected with HSV-1 strain KOS or tkLTRZ1 for the indicated times are shown. (A to C) The data represent means ± SE (error bars) for >3 samples per data point. For panels D and E, each point on the scattergram represents an individual sample, and the horizontal lines represent the mean values for each group.
FIG 2
FIG 2
Presence of T cells in tissues of ICR mice infected with HSV-1. The indicated tissues of mice that were mock infected or infected with HSV-1 strain KOS or tkLTRZ1 for 7 days were harvested to quantify cells positive for CD4 (A to C) or CD8 (D to F) by flow cytometry. The data represent means + SE (error bars) for >3 samples per group, with samples being derived from individual mice.
FIG 3
FIG 3
Persistent infection by tkLTRZ1 in ICR nude mice. (A) Viral titers in the eyes, trigeminal ganglia, and brain stems of mice infected with HSV-1 strain tkLTRZ1 for 28 days are shown. Each point on the scattergram represents an individual sample, and the horizontal lines represent the mean values for each group. BD, below the detection limit. **, P < 0.01; ***, P < 0.001. (B and C) Brain stems of mock-infected or infected mice were harvested at 28 days postinfection and stained with antibodies against HSV-1 (B) or with antibodies against HSV-1 glycoprotein C (gC) or the neuron-specific marker NeuN or with Hoechst dye for DNA in nucleus (C). Data are representative of results from at least 3 samples per group from two independent experiments.
FIG 4
FIG 4
Persistent infection by dlsptk in ICR nude mice. Viral titers in the eyes, trigeminal ganglia, and brain stems of mice infected with HSV-1 strain dlsptk for 28 days are shown. Each point on the scattergram represents an individual sample, and the horizontal lines represent the mean values for each group. BD, below the detection limit. ***, P < 0.001.
FIG 5
FIG 5
Persistent infection by 294dlTKA in ICR or BALB/c nude mice. Viral titers in the eyes, trigeminal ganglia, and brain stems of ICR nude mice (A) or BALB/c nude mice (B) infected with HSV-1 strain 294dlTKA for 28 days are shown. Each point on the scattergram represents an individual sample, and the horizontal lines represent the mean values for each group. BD, below the detection limit. **, P < 0.01; ***, P < 0.001.

Similar articles

Cited by

References

    1. Roizman B, Knipe DM, Whitley RJ. 2013. Herpes simplex viruses, p 1823–1897. In Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Racaniello VR, Roizman B (ed), Fields virology, 6th ed, vol 2 Lippincott Williams & Wilkins, Philadelphia, PA.
    1. Smith JS, Robinson NJ. 2002. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 186:S3–S28. doi:10.1086/343739. - DOI - PubMed
    1. Coen DM, Schaffer PA. 2003. Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets. Nat Rev Drug Discov 2:278–288. doi:10.1038/nrd1065. - DOI - PubMed
    1. Horsburgh BC, Chen SH, Hu A, Mulamba GB, Burns WH, Coen DM. 1998. Recurrent acyclovir-resistant herpes simplex in an immunocompromised patient: can strain differences compensate for loss of thymidine kinase in pathogenesis? J Infect Dis 178:618–625. doi:10.1086/515375. - DOI - PubMed
    1. Stranska R, van Loon AM, Polman M, Beersma MF, Bredius RG, Lankester AC, Meijer E, Schuurman R. 2004. Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipients. Antivir Ther 9:565–575. - PubMed

Publication types

MeSH terms